| 000 | 03010nam a22005655i 4500 | ||
|---|---|---|---|
| 001 | 978-3-642-14541-4 | ||
| 003 | DE-He213 | ||
| 005 | 20140220083745.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 101120s2011 gw | s |||| 0|eng d | ||
| 020 |
_a9783642145414 _9978-3-642-14541-4 |
||
| 024 | 7 |
_a10.1007/978-3-642-14541-4 _2doi |
|
| 050 | 4 | _aRM1-950 | |
| 072 | 7 |
_aMMG _2bicssc |
|
| 072 | 7 |
_aMED071000 _2bisacsh |
|
| 082 | 0 | 4 |
_a615 _223 |
| 100 | 1 |
_aFromm, Martin F. _eeditor. |
|
| 245 | 1 | 0 |
_aDrug Transporters _h[electronic resource] / _cedited by Martin F. Fromm, Richard B. Kim. |
| 264 | 1 |
_aBerlin, Heidelberg : _bSpringer Berlin Heidelberg, _c2011. |
|
| 300 |
_aX, 454 p. _bonline resource. |
||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 347 |
_atext file _bPDF _2rda |
||
| 490 | 1 |
_aHandbook of Experimental Pharmacology, _x0171-2004 ; _v201 |
|
| 505 | 0 | _aFrom the contents -- Preface -- Organic anion transporting polypeptides (OATPs); In vitro and in vivo evidence for the importance of organic anion transporters (OATs) in drug therapy; In vitro and in vivo evidence for the importance of organic cation transporters (OCTs, MATEs) in drug therapy; Intestinal bile salt transporters (ASBT and OST alpha/beta); hepatic bile salt transporters (NTCP and BSEP); Importance of P-glycoprotein for drug-drug interactions; Importance of the multidrug resistance protein (MRP) family for pathophysiology and drug therapy; Importance of breast cancer resistance protein transporters (BCRP); Molecular mechanisms of drug transporters regulation; In vivo probes of drug transport. | |
| 520 | _aIt is increasingly recognized that various transporter proteins are expressed throughout the body and determine absorption, tissue distribution, biliary and renal elimination of endogenous compounds and drugs and drug effects. This book will give an overview on the transporter families which are most important for drug therapy. Most chapters will focus on one transporter family highlighting tissue expression, substrates, inhibitors, knock-out mouse models and clinical studies. | ||
| 650 | 0 | _aMedicine. | |
| 650 | 0 | _aHuman physiology. | |
| 650 | 0 | _aDrug interactions. | |
| 650 | 0 | _aToxicology. | |
| 650 | 0 | _aPharmaceutical technology. | |
| 650 | 0 | _aClinical medicine. | |
| 650 | 0 | _aNephrology. | |
| 650 | 1 | 4 | _aBiomedicine. |
| 650 | 2 | 4 | _aPharmacology/Toxicology. |
| 650 | 2 | 4 | _aPharmaceutical Sciences/Technology. |
| 650 | 2 | 4 | _aHuman Physiology. |
| 650 | 2 | 4 | _aDrug Resistance. |
| 650 | 2 | 4 | _aHepatology. |
| 650 | 2 | 4 | _aNephrology. |
| 700 | 1 |
_aKim, Richard B. _eeditor. |
|
| 710 | 2 | _aSpringerLink (Online service) | |
| 773 | 0 | _tSpringer eBooks | |
| 776 | 0 | 8 |
_iPrinted edition: _z9783642145407 |
| 830 | 0 |
_aHandbook of Experimental Pharmacology, _x0171-2004 ; _v201 |
|
| 856 | 4 | 0 | _uhttp://dx.doi.org/10.1007/978-3-642-14541-4 |
| 912 | _aZDB-2-SBL | ||
| 999 |
_c106961 _d106961 |
||